Advertisement

Neurological Sciences

, Volume 39, Issue 7, pp 1237–1244 | Cite as

The Italian validation of the minimal assessment of cognitive function in multiple sclerosis (MACFIMS) and the application of the Cognitive Impairment Index scoring procedure in MS patients

  • Ornella Argento
  • Chiara C. Incerti
  • Maria E. Quartuccio
  • Giuseppe Magistrale
  • Ada Francia
  • Carlo Caltagirone
  • Valerio Pisani
  • Ugo Nocentini
Original Article

Abstract

Cognitive dysfunction occurs in almost 50–60% of patients with multiple sclerosis (MS) even in early stages of the disease and affects different aspects of patient’s life. Aims of the present study were (1) to introduce and validate an Italian version of the minimal assessment of cognitive functions in MS (MACFIMS) battery and (2) to propose the use of the Cognitive Impairment Index (CII) as a scoring procedure to define the degree of impairment in relapsing-remitting (RRMS) and secondary-progressive (SPMS) patients. A total of 240 HC and 123 MS patients performed the Italian version of the MACFIMS composed by the same tests as the original except for the Paced Auditory Serial Addition Test. The CII was derived for each score of the 11 scales for participants of both groups. The results of the study show that cognitive impairment affects around 50% of our sample of MS patients. In RRMS group, only the 15.7% of patients reported a severe impairment, while in the group of SPMS, the 51.4% of patients felt in the “severely impaired” group. Results are in line with previously reported percentages of impairment in MS patients, showing that the calculation of the CII applied to the Italian version of the MACFIMS is sensitive and reliable in detecting different degrees of impairment in MS patients.

Keywords

MACFIMS Cognitive Impairment Index Multiple sclerosis Italian validation 

Notes

Compliance with ethical standards

Conflict of interest

The authors report no conflicting financial interests.

Ethical approval

All procedures involving human participants performed in this study were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The study was approved by the local ethical committee on May 28, 2014 (Prot. CE/PROG.444-09). Informed consent was obtained from all individual participants included in the study. We thank the patients for their willing participation in the study.

References

  1. 1.
    Chiaravalloti ND, DeLuca J (2008) Cognitive impairment in multiple sclerosis. Lancet Neurol 7(12):1139–1151.  https://doi.org/10.1016/S1474-4422(08)70259-X CrossRefPubMedGoogle Scholar
  2. 2.
    Campbell J, Rashid W, Cercignani M, Langdon D (2016) Cognitive impairment among patients with multiple sclerosis: associations with employment and quality of life. Postgrad Med J.  https://doi.org/10.1136/postgradmedj-2016-134071
  3. 3.
    Magistrale G, Pisani V, Argento O, Incerti CC, Bozzali M, Cadavid D, Caltagirone C, Medori R, DeLuca J, Nocentini U (2015) Validation of the World Health Organization disability assessment schedule II (WHODAS-II) in patients with multiple sclerosis. Mult Scler 21(4):448–456.  https://doi.org/10.1177/1352458514543732 CrossRefPubMedGoogle Scholar
  4. 4.
    Langdon DW (2011) Cognition in multiple sclerosis. Curr Opin Neurol 24:244–249.  https://doi.org/10.1097/WCO.0b013e328346a43b CrossRefPubMedGoogle Scholar
  5. 5.
    Morrow SA, Drake A, Zivadinov R, Munschauer F, Weinstock-Guttman B, Benedict RH (2010) Predicting loss of employment over three years in multiple sclerosis: clinically meaningful cognitive decline. Clin Neuropsychol 24(7):1131–1145.  https://doi.org/10.1080/13854046.2010.511272 CrossRefPubMedGoogle Scholar
  6. 6.
    Incerti CC, Magistrale G, Argento O, Pisani V, Di Battista G, Ferraro E, Caltagirone C, Benedict RH, Nocentini U (2015) Occupational stress and personality traits in multiple sclerosis: a preliminary study. Mult Scler Relat Disord 4(4):315–319.  https://doi.org/10.1016/j.msard.2015.06.001 CrossRefGoogle Scholar
  7. 7.
    Amato MP, Ponziani G, Pracucci G, Bracco L, Siracusa G, Amaducci L (1995) Cognitive impairment in early-onset multiple sclerosis. Pattern, predictors, and impact on everyday life in a 4-year follow-up. Arch Neurol 52(2):168–172CrossRefPubMedGoogle Scholar
  8. 8.
    Bruce JM, Hancock LM, Arnett P, Lynch S (2010) Treatment adherence in multiple sclerosis: association with emotional status, personality, and cognition. J Behav Med 33(3):219–227.  https://doi.org/10.1007/s10865-010-9247-y CrossRefPubMedGoogle Scholar
  9. 9.
    Rao SM, and the Cognitive Function Study Group of the National Multiple Sclerosis Society (1990) A manual for the brief repeatable battery of neuropsychologic tests in multiple sclerosis. Medical College of Wisconsin, MilwaukeeGoogle Scholar
  10. 10.
    Buschke H (1984) Cued recall in amnesia. J Clin Exp Neuropsychol 6(4):433–440CrossRefGoogle Scholar
  11. 11.
    Rao SM, Hammeke TA, McQuillen MP, Khatri BO, Lloyd D (1984) Memory disturbance in chronic progressive multiple sclerosis. Arch Neurol 41(6):625–631CrossRefPubMedGoogle Scholar
  12. 12.
    Smith A (1982) Symbol digit modalities test (SDMT) manual (revised) western psychological services. Los AngelesGoogle Scholar
  13. 13.
    Spreen O, Strauss E (1991) Controlled oral word association (word fluency). A compendium of neuropsychological tests. Oxford Univ Pr, Oxford, pp 219–227Google Scholar
  14. 14.
    Gronwall DMA (1977) Paced auditory serial-addition task: a measure of recovery from concussion. Percept Mot Skills 44(2):367–373CrossRefPubMedGoogle Scholar
  15. 15.
    Goodglass H, Kaplan E, Barresi B (2001) The assessment of aphasia and related disorders. Lippincott Williams & WilkinsGoogle Scholar
  16. 16.
    Boringa JB, Lazeron RH, Reuling IE, Ader HJ, Pfennings LE, Lindeboom J, de Sonneville LM, Kalkers NF, Polman CH (2001) The brief repeatable battery of neuropsychological tests: normative values allow application in multiple sclerosis clinical practice. Mult Scler 7(4):263–267.  https://doi.org/10.1177/135245850100700409 CrossRefPubMedGoogle Scholar
  17. 17.
    Delis DC, Kramer JH, Kaplan E, Ober BA (2000) CVLT-II: California verbal learning test: adult version. Psychological Corporation, San AntonioGoogle Scholar
  18. 18.
    Benedict RH, Schretlen D, Groninger L, Dobraski M, Shpritz B (1996) Revision of the brief visuospatial memory test: studies of normal performance, reliability, and validity. Psychol Assess 8(2):145–153CrossRefGoogle Scholar
  19. 19.
    Delis DC, Kaplan E, Kramer JH (2001) Delis-Kaplan executive function system (D-KEFS). Harcourt Assessment Company, Psychological Corporation, San AntonioGoogle Scholar
  20. 20.
    Benton AL, Hamsher KDES, Varney NR, Spreen O (1983) Contributions to Neuropsychological Assessment: A Clinical Manual. Oxford University Press, New YorkGoogle Scholar
  21. 21.
    Benedict RH, Fischer JS, Archibald CJ, Arnett PA, Beatty WW, Bobholz J et al (2002) Minimal neuropsychological assessment of MS patients: a consensus approach. Clin Neuropsychol 16(3):381–397.  https://doi.org/10.1017/S1355617709990750 CrossRefPubMedGoogle Scholar
  22. 22.
    Benedict RH, Amato MP, Boringa J, Brochet B, Foley F, Fredrikson S et al (2012) Brief international cognitive assessment for MS (BICAMS): international standards for validation. BMC Neurol 12(1):55–898.  https://doi.org/10.1177/1352458511431076 CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Goretti B, Niccolai C, Hakiki B, Sturchio A, Falautano M, Minacapelli E, Martinelli V, Incerti C, Nocentini U, Murgia M, Fenu G, Cocco E, Marrosu MG, Garofalo E, Ambra FI, Maddestra M, Consalvo M, Viterbo RG, Trojano M, Losignore NA, Zimatore GB, Pietrolongo E, Lugaresi A, Langdon D, Portaccio E, Amato MP (2014) The brief international cognitive assessment for multiple sclerosis (BICAMS): normative values with gender, age and education corrections in the Italian population. BMC Neurol 14(1):171.  https://doi.org/10.1186/s12883-014-0171-6 CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Erlanger DM, Kaushik T, Caruso LS, Benedict RH, Foley FW, Wilken J, Cadavid D, DeLuca J (2014) Reliability of a cognitive endpoint for use in a multiple sclerosis pharmaceutical trial. J Neurol Sci 340(1):123–129.  https://doi.org/10.1016/j.jns.2014.03.009 CrossRefPubMedGoogle Scholar
  25. 25.
    Sonder JM, Burggraaff J, Knol DL, Polman CH, Uitdehaag BM (2014) Comparing long-term results of PASAT and SDMT scores in relation to neuropsychological testing in multiple sclerosis. Mult Scler 20(4):481–488.  https://doi.org/10.1177/1352458513501570 CrossRefPubMedGoogle Scholar
  26. 26.
    Argento O, Smerbeck A, Pisani V, Magistrale G, Incerti CC, Caltagirone C, Benedict RH, Nocentini U (2016) Regression-based norms for the brief visuospatial memory test-revised in Italian population and application in MS patients. Clin Neuropsychol 30(1):1469–1478.  https://doi.org/10.1080/13854046.2016.1183713 CrossRefPubMedGoogle Scholar
  27. 27.
    Folstein MF, Folstein SE, McHugh PR, Fanjiang G (2000) Mini-Mental State Examination: MMSE user's guide. Psychology Assessment Resources, OdessaGoogle Scholar
  28. 28.
    Measso G, Cavarzeran F, Zappalà G, Lebowitz BD, Crook TH, Pirozzolo FJ, Amaducci LA, Massari D, Grigoletto F (1993) The mini-mental state examination: normative study of an Italian random sample. Dev Neuropsychol 9(2):77–85.  https://doi.org/10.1080/87565649109540545 CrossRefGoogle Scholar
  29. 29.
    Polman CH, Reingold SC, Edan G, Filippi M, Hartung HP, Kappos L, Lublin FD, Metz LM, McFarland HF, O'Connor PW, Sandberg-Wollheim M, Thompson AJ, Weinshenker BG, Wolinsky JS (2005) Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald criteria”. Ann Neurol 58(6):840–846.  https://doi.org/10.1002/ana.20703 CrossRefPubMedGoogle Scholar
  30. 30.
    Dusankova JB, Kalincik T, Havrdova E, Benedict RH (2012) Cross cultural validation of the minimal assessment of cognitive function in multiple sclerosis (MACFIMS) and the brief international cognitive assessment for multiple sclerosis (BICAMS). Clin Neuropsychol 26(7):1186–1200.  https://doi.org/10.1080/13854046.2012.725101 CrossRefPubMedGoogle Scholar
  31. 31.
    Migliore S, Ghazaryan A, Simonelli I, Pasqualetti P, Landi D, Palmieri MG, Moffa F, Rinaldi P, Vernieri F, Filippi MM (2016) Validity of the minimal assessment of cognitive function in multiple sclerosis (MACFIMS) in the Italian population. Neurol Sci 37(8):1261–1270.  https://doi.org/10.1007/s10072-016-2578-x CrossRefPubMedGoogle Scholar
  32. 32.
    Nocentini U, Giordano A, Di Vincenzo S, Panella M, Pasqualetti P (2006) The symbol digit modalities test-oral version: Italian normative data. Funct Neurol 21(2):93–96PubMedGoogle Scholar
  33. 33.
    Mattioli F, Stampatori C, Bellomi F, Scarpazza C, Galli P, Guarneri C, Corso B, Montomoli C, Niccolai C, Goretti B, Amato MP, Riboni E, Tomasina CD, Falautano M, Capra R (2014) Assessing executive function with the D-KEFS sorting test: normative data for a sample of the Italian adult population. Neurol Sci 35(12):1895–1902.  https://doi.org/10.1007/s10072-014-1857-7 CrossRefPubMedGoogle Scholar
  34. 34.
    Camp SJ, Stevenson VL, Thompson AJ, Miller DH, Borras C, Auriacombe S, Brochet B, Falautano M, Filippi M, Herisse-Dulo L, Montalban X, Parrcira E, Polman CH, de Sa J, Langdon DW (1999) Cognitive function in primary progressive and transitional progressive multiple sclerosis. Brain 122(7):1341–1348CrossRefPubMedGoogle Scholar
  35. 35.
    Calabrese M, Agosta F, Rinaldi F, Mattisi I, Grossi P, Favaretto A, Atzori M, Bernardi V, Barachino L, Rinaldi L, Perini P, Gallo P, Filippi M (2009) Cortical lesions and atrophy associated with cognitive impairment in relapsing-remitting multiple sclerosis. Arch Neurol 66(9):1144–1150.  https://doi.org/10.1001/archneurol.2009.174 CrossRefPubMedGoogle Scholar
  36. 36.
    Amato MP, Langdon D, Montalban X, Benedict RH, DeLuca J, Krupp LB et al (2013) Treatment of cognitive impairment in multiple sclerosis: position paper. J Neurol 260(6):1452–1468.  https://doi.org/10.1007/s00415-012-6678-0 CrossRefPubMedGoogle Scholar
  37. 37.
    Miller E, Morel A, Redlicka J, Miller I, Saluk J (2017) Pharmacological and non-pharmacological therapies of cognitive impairment in multiple sclerosis. Curr Neuropharmacol.  https://doi.org/10.2174/1570159X15666171109132650
  38. 38.
    Desmond DW, Glenwick DS, Stern Y, Tatemichi TK (1994) Sex differences in the representation of visuospatial functions in the human brain. Rehabil Psychol 39:3–14CrossRefGoogle Scholar
  39. 39.
    Goyette SR, McCoy JG, Kennedy A, Sullivan M (2012) Sex differences on the judgment of line orientation task: a function of landmark presence and hormonal status. Physiol Behav 105(4):1045–1051CrossRefPubMedGoogle Scholar
  40. 40.
    Comi G, Filippi M, Martinelli V, Campi A, Rodegher M, Alberoni M et al (1995) Brain MRI correlates of cognitive impairment in primary and secondary progressive multiple sclerosis. J Neurol Sci 132(2):22–227CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Italia S.r.l., part of Springer Nature 2018

Authors and Affiliations

  1. 1.Neurology and Neurorehabilitation UnitI.R.C.C.S. “Santa Lucia” FoundationRomeItaly
  2. 2.Department of Systems MedicineUniversity of Rome “Tor Vergata”RomeItaly
  3. 3.Department of Neurological SciencesUniversity of Rome “Sapienza”RomeItaly

Personalised recommendations